Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a positive single-stranded RNA virus, engages in complex interactions with host cell proteins throughout its life cycle. While these interactions enable the host to recognize and inhibit viral replication, they also facilitate essential viral processes such as transcription, translation, and replication. Many aspects of these virus-host interactions remain poorly understood. Here, we employed the catRAPID algorithm and utilized the RNA-protein interaction detection coupled with mass spectrometry technology to predict and validate the host proteins that specifically bind to the highly structured 5′ and 3′ terminal regions of the SARS-CoV-2 RNA. Among the interactions identified, we prioritized pseudouridine synthase PUS7, which binds to both ends of the viral RNA. Using nanopore direct RNA sequencing, we discovered that the viral RNA undergoes extensive post-transcriptional modifications. Modified consensus regions for PUS7 were identified at both terminal regions of the SARS-CoV-2 RNA, including one in the viral transcription regulatory sequence leader. Collectively, our findings offer insights into host protein interactions with the SARS-CoV-2 UTRs and highlight the likely significance of pseudouridine synthases and other post-transcriptional modifications in the viral life cycle. This new knowledge enhances our understanding of virus-host dynamics and could inform the development of targeted therapeutic strategies.

Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome / R. Giambruno, E. Zacco, C. Ugolini, A. Vandelli, L. Mulroney, M. D'Onghia, B. Giuliani, E. Criscuolo, M. Castelli, N. Clementi, M. Clementi, N. Mancini, T. Bonaldi, S. Gustincich, T. Leonardi, G.G. Tartaglia, F. Nicassio. - In: MOLECULAR THERAPY NUCLEIC ACIDS. - ISSN 2162-2531. - 34:(2023), pp. 102052.1-102052.17. [10.1016/j.omtn.2023.102052]

Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome

C. Ugolini;M. D'Onghia;M. Clementi;T. Bonaldi
Formal Analysis
;
2023

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a positive single-stranded RNA virus, engages in complex interactions with host cell proteins throughout its life cycle. While these interactions enable the host to recognize and inhibit viral replication, they also facilitate essential viral processes such as transcription, translation, and replication. Many aspects of these virus-host interactions remain poorly understood. Here, we employed the catRAPID algorithm and utilized the RNA-protein interaction detection coupled with mass spectrometry technology to predict and validate the host proteins that specifically bind to the highly structured 5′ and 3′ terminal regions of the SARS-CoV-2 RNA. Among the interactions identified, we prioritized pseudouridine synthase PUS7, which binds to both ends of the viral RNA. Using nanopore direct RNA sequencing, we discovered that the viral RNA undergoes extensive post-transcriptional modifications. Modified consensus regions for PUS7 were identified at both terminal regions of the SARS-CoV-2 RNA, including one in the viral transcription regulatory sequence leader. Collectively, our findings offer insights into host protein interactions with the SARS-CoV-2 UTRs and highlight the likely significance of pseudouridine synthases and other post-transcriptional modifications in the viral life cycle. This new knowledge enhances our understanding of virus-host dynamics and could inform the development of targeted therapeutic strategies.
catRAPID; MT: RNA/DNA editing; nanocompore; nanopore direct-RNA sequencing; protein-RNA interactions; proximity biotinylation; pseudouridine; PUS7; RNA-binding proteins; SARS-CoV-2
Settore BIOS-08/A - Biologia molecolare
Settore BIOS-10/A - Biologia cellulare e applicata
   National Center for Gene Therapy and Drugs based on RNA Technology (CN3 RNA)
   CN3 RNA
   MINISTERO DELL'UNIVERSITA' E DELLA RICERCA
   CN00000041

   MultIscale precision therapies for NeuroDEvelopmental Disorders
   MINDED
   European Commission
   Horizon 2020 Framework Programme
   754490
2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
giambruno_bonaldi_UPS.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 2.91 MB
Formato Adobe PDF
2.91 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1195296
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
  • OpenAlex 13
social impact